Graham Capital Management’s ResMed RMD Stock Holding History

Graham Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.88M	Sell	17,272 -4,205	-20%	-$1.05M	0.09%	160
2025 Q4	$5.17M	Buy	21,477 +13,801	+180%	+$3.53M	0.12%	109
2025 Q3	$2.1M	Sell	7,676 -9,315	-55%	-$2.54M	0.03%	221
2025 Q2	$4.38M	Buy	+16,991	New	+$4.05M	0.07%	165
2025 Q1	–	Sell	-1,240	Closed	-$284K	–	1483
2024 Q4	$284K	Sell	1,240 -3,939	-76%	-$948K	﹤0.01%	956
2024 Q3	$1.26M	Buy	5,179 +1,805	+53%	+$403K	0.02%	395
2024 Q2	$646K	Buy	+3,374	New	+$685K	0.01%	504
2023 Q3	–	Sell	-25,668	Closed	-$5.61M	–	1251
2023 Q2	$5.61M	Buy	25,668 +819	+3%	+$183K	0.16%	98
2023 Q1	$5.44M	Buy	24,849 +7,441	+43%	+$1.61M	0.17%	80
2022 Q4	$3.62M	Buy	17,408 +13,445	+339%	+$2.95M	0.11%	106
2022 Q3	$865K	Buy	+3,963	New	+$902K	0.03%	545

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Graham Capital Management's RMD Position: Q1 2026 in Review

Graham Capital Management reduced its ResMed (RMD) stake by 20% in Q1 2026, selling an estimated $1.05M and leaving 17,272 shares worth $3.88M. The position accounts for 0.09% of the portfolio, ranked #160.

Graham Capital Management first reported a position in RMD in Q3 2022 and has held it in 11 quarters since. The position peaked at $5.61M in Q2 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Graham Capital Management held 17,272 shares of ResMed worth $3.88M as of Q1 2026.
Graham Capital Management sold 4,205 ResMed shares in Q1 2026, an estimated $1.05M.
ResMed made up 0.09% of Graham Capital Management's portfolio in Q1 2026, its #160 holding.
Graham Capital Management first reported a position in ResMed in Q3 2022 and has held it in 11 quarters since.
Graham Capital Management's ResMed position peaked at $5.61M in Q2 2023.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.